The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage

References

• To KK, Sridhar S, Chiu KH, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect. 2021;10:507–535. doi:10.1080/22221751.2021.1898291.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi:10.1016/S0140-6736(20)30154-9.
   PubMed Web of Science ®Google Scholar
• Iketani S, Liu L, Guo Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022. doi:10.1038/s41586-022-04594-4
   Web of Science ®Google Scholar
• Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538); doi:10.1126/science.abg3055.
   Web of Science ®Google Scholar
• Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021;596:276–280. doi:10.1038/s41586-021-03777-9.
   PubMed Web of Science ®Google Scholar
• Shuai H, Chan JF, Hu B, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 omicron. Nature. 2022;603:693–699. doi:10.1038/s41586-022-04442-5.
   PubMed Web of Science ®Google Scholar
• Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–446. doi:10.1016/S0140-6736(22)00017-4.
   PubMed Web of Science ®Google Scholar
• Uraki R, Kiso M, Iida S, et al. Characterization and antiviral susceptibility of SARS-CoV-2 omicron/BA.2. Nature. 2022. doi:10.1038/s41586-022-04856-1
   Web of Science ®Google Scholar
• Yu J, Collier AY, Rowe M, et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 variants. Engl J Med. 2022;386:1579–1580. doi:10.1056/NEJMc2201849.
   PubMed Web of Science ®Google Scholar
• Bruel T, Hadjadj J, Maes P, et al. Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies. Nat Med. 2022. doi:10.1038/s41591-022-01792-5
   PubMed Web of Science ®Google Scholar
• Iketani S, Liu L, Guo Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604:553–556. doi:10.1038/s41586-022-04594-4.
   PubMed Web of Science ®Google Scholar
• Yuan S, Ye ZW, Liang R, et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 omicron in Syrian hamsters. Science. 2022: eabn8939, doi:10.1126/science.abn8939.
   Web of Science ®Google Scholar
• Chen LL, Abdullah SMU, Chan WM, et al. Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nat Commun. 2022;13:3618, doi:10.1038/s41467-022-31395-0.
   PubMed Web of Science ®Google Scholar
• Yuan S, Yin X, Meng X, et al. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature. 2021;593:418–423. doi:10.1038/s41586-021-03431-4.
   PubMed Web of Science ®Google Scholar
• Shi PY, Plante J, Liu Y, et al. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility. Res Sq. 2020. doi:10.21203/rs.3.rs-70482/v1.
   PubMedGoogle Scholar
• Yuan S, Wang R, Chan JF, et al. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat Microbiol. 2020;5:1439–1448. doi:10.1038/s41564-020-00802-x.
   PubMed Web of Science ®Google Scholar
• Varadi M, Anyango S, Deshpande M, et al. Alphafold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50:D439–D444. doi:10.1093/nar/gkab1061.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–589. doi:10.1038/s41586-021-03819-2.
   PubMed Web of Science ®Google Scholar
• Ye ZW, Ong CP, Tang K, et al. Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals. Cell Mol Immunol. 2022. doi:10.1038/s41423-022-00855-4.
   Web of Science ®Google Scholar
• Teng S, Sobitan A, Rhoades R, et al. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity. Brief Bioinform. 2021;22:1239–1253. doi:10.1093/bib/bbaa233.
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Huo J, Zhou D, et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185:467–484 e415. doi:10.1016/j.cell.2021.12.046.
   PubMed Web of Science ®Google Scholar
• Qu Y, Zhang X, Wang M, et al. Antibody cocktail exhibits broad neutralization activity against SARS-CoV-2 and SARS-CoV-2 variants. Virol Sin. 2021;36:934–947. doi:10.1007/s12250-021-00409-4.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Gilchuk P, Case JB, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020;584:443–449. doi:10.1038/s41586-020-2548-6.
   PubMed Web of Science ®Google Scholar
• Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022;602(7898):664–70. doi:10.1038/s41586-021-04386-2.
   PubMed Web of Science ®Google Scholar
• Starr TN, Greaney AJ, Hilton SK, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182:1295–1310 e1220. doi:10.1016/j.cell.2020.08.012.
   PubMed Web of Science ®Google Scholar
• Zahradnik J, Marciano S, Shemesh M, et al. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nature Microbiology. 2021;6:1188–1198. doi:10.1038/s41564-021-00954-4.
   PubMed Web of Science ®Google Scholar